The Digital Health Applications Ordinance (DiGAV) is a central component for the app on prescription. Since 1 October, there is now a renewed version that focuses primarily on more data protection and data security as well as interoperability with the electronic patient record (ePA) and with other devices and systems.
The reason for the revision of the DiGAV are changes in the Digital Care and Nursing Modernisation Act as well as changes in the legal framework and the audit of DiGA.
But what will change in detail? And what do manufacturers have to consider when developing a DiGA in order to be included in the DiGA directory?